Our observations that MEG3 activation in somatotroph cells due to an activating GNAS mutation, concomitantly the inactivation of Wnt/β-catenin pathway and inhibition of EMT may explain distinctive somatotroph adenoma features. This evidence concerns the gene MEG3 and growth hormone-secreting pituitary adenoma.